The abstract is read at the publisher; the summary is JClub's.
In adult inpatients with alcohol withdrawal syndrome, initiating phenobarbital vs diazepam on admission shows no difference in hospital length of stay (4.1 vs 4.3 days) or invasive mechanical ventilation (3.1% vs 2.7%).
- Why it matters: Phenobarbital use is rising, but evidence comparing it to more pharmacokinetically similar long-acting, self-tapering benzodiazepines like diazepam has been limited.
- What they did: Using Premier Healthcare Database data (October 2022 to August 2024) from 754 US acute care hospitals, the study emulated a randomized trial with targeted maximum likelihood estimation and ensemble machine learning.
- The result: Among 24,643 patients, phenobarbital and diazepam had similar effectiveness and safety, with only self-directed discharge differing (9.5% vs 12.6%), suggesting near therapeutic equivalence.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.